Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Trillium Therapeutics Inc. T.TRIL

Trillium Therapeutics Inc is a clinical-stage immuno-oncology company that is engaged in developing therapies for the treatment of cancer. It has two clinical programs, TTI-621 and TTI-622, that target CD47. The company operates in the United States and Canada.


TSX:TRIL - Post by User

Bullboard Posts
Post by mediascan59on Mar 12, 2010 4:52pm
550 Views
Post# 16878225

Friday TA

Friday TAWell, it looks like the 30's didn't hold on for the stock and the bears were in control the last two days.
I sold off my .31 and .255 buys and will see where she goes from here.
There were two recent tests of .27, so most likely a third coming again.
They daily says it could now be a few days before any sign of direction, and the weekly says she is about to break downward.
I always have that .245 gap in the back of my head and wish we had have taken it out this past week already.
The stock needs to hold .27, or else the stock will want to test that gap once again.
The stock desparately needs some good news to kick start it again.
Nothing more to say for now.

Mediascan
Bullboard Posts